IBT is a clinical stage pharmaceutical company with a vision to develop drugs influencing the infant microbiome, and thereby prevent or treat rare diseases affecting infants.

Pharmaceutical

Infant Bacterial Therapeutics

Infant Bacterial Therapeutics' headquarters in Stockholm, Sweden

Staffan Strömberg

Nigel Titford

Maria Ekdahl

Anders Kronström

Eva Idén

Anthon Jahreskog

Margareta Hagman

Peter Rothschild

Josef Neu

Kristina Sjöblom Nygren

Thomas J. Schnitzer

Sanjiv Sharma

Advisory and Governance

Clinical and Development Team

Leadership Team

Infant Bacterial Therapeutics

Org chart

Board & advisors

Teams

Advisory and Governance

Clinical and Development Team

Leadership Team

Offices

Similar companies